Goldfinch Bio is Drug Discovery in United States that focus on Diabetic Nephropathy business. Founded in 2016. They cover business area such as developer, precision medicine, patient, kidney disease, development, Focal Segmental Glomerulosclerosis, Diabetic Nephropathy, (DN, leverage advance, genetic, genomic, stem cell, biomarker, science, healthcare professional.
2016
( 10 years old in 2026 )
Diabetic Nephropathy
-
215 First Street
4th Floor
Cambridge, MA 02142
United States
Private
developerprecision medicinepatientkidney diseasedevelopmentFocal Segmental GlomerulosclerosisDiabetic Nephropathy(DNleverage advancegeneticgenomicstem cellbiomarkersciencehealthcare professional
* We use standard office opening hours in near Goldfinch Bio's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Goldfinch Bio is Drug Discovery business from United States that founded in 2016 (10 years old in 2026), Goldfinch Bio business is focusing on Diabetic Nephropathy.
Goldfinch Bio headquarter office and corporate office address is located in 215 First Street 4th Floor Cambridge, MA 02142 United States.
Goldfinch Bio was founded in United States.
In 2026, Goldfinch Bio is currently focus on Diabetic Nephropathy sector.
Above is snippet of Google Trends for "Diabetic Nephropathy" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Goldfinch Bio, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
